Sarda Proteins swings to profit on revenue surge to ₹12.99 cr
Revenue jumped from ₹65 lakh in the previous quarter to ₹12.99 cr; net profit of ₹1.66 cr vs loss a year ago. Board also approved office shift and new independent director.
— 2 earlier stories on Sarda Proteins Ltd. →What's new
- Revenue at ₹12.99 cr vs ₹65 lakh in Mar quarter and ₹10.95 cr YoY.
- Net profit of ₹1.66 cr against a loss of ₹49.34 lakh in the year-ago quarter.
- Company says it now operates solely in renewable energy solar cell products.
Why this matters
Sarda Proteins, a micro-cap with a market cap of ₹84 cr, just reported its first meaningful revenue and profit in years. The sequential revenue explosion from ₹65 lakh to ₹12.99 cr signals the solar cell pivot may be gaining traction. A clean audit adds credibility.
What we're watching
- Whether revenue sustains above ₹12 cr in the coming quarters.
- Any disclosure of major customers or order book for solar cell products.
- Further board reconstitution after recent MD exit and capital increase.
The full read
Sarda Proteins just posted a quarter that could redefine its narrative. Revenue hit ₹12.99 cr in Jun 2026, up from ₹65 lakh in the preceding quarter and ₹10.95 cr a year ago. Net profit swung to ₹1.66 cr from a loss of ₹49.34 lakh. The company, once an edible oil micro-cap, now says it operates only in solar cell products, a pivot validated by these numbers. The sequential explosion is the real story: from near-zero quarterly sales to ₹12.99 cr in three months. With a market cap of ₹84 cr, this quarter's profit is a sharp improvement, but the revenue jump suggests a new business ramp. One quarter does not make a trend. For now, the board also approved an office shift and a new independent woman director. The clean audit report is a plus. This looks like a genuine turnaround, but sustainability is the open question.
Questions answered
- How did Sarda Proteins' revenue jump so sharply?
- The company has pivoted to renewable energy solar cell products. Jun quarter revenue was ₹12.99 cr, up from just ₹65 lakh in the preceding quarter and ₹10.95 cr a year ago. The sequential leap suggests new business coming online.
- What was the net profit for the quarter?
- Net profit stood at ₹1.66 cr, compared to a loss of ₹49.34 lakh in the same quarter last year and a profit of ₹1 cr in the Mar quarter.
- What other board decisions were announced?
- The board approved shifting the registered office within Alwar, Rajasthan, and establishing a corporate office in Rajkot, Gujarat. Ms. Minal Surendra Jain was appointed as an independent woman director for five years, subject to shareholder approval.
- What was the auditor's opinion?
- The auditors issued an unmodified (clean) limited review report on the standalone financial results.
- Is the company still in the edible oil business?
- No. The company stated it now operates solely in the renewable energy solar cell products segment. This follows recent board restructuring and an increase in authorised capital to ₹100 cr.
Sarda Proteins Ltd.
Latest quarter · Jun 2026
Strength & growth
Story so far
All notes on SRDAPRT →- 15 Jul 2026 · 5:58 PM IST Sarda Proteins swings to profit on revenue surge to ₹12.99 cr
- 24d ago Sarda Proteins loses MD, three directors after Onix open offer
- 27d ago Sarda Proteins plans eight-fold jump in authorized capital to ₹100 cr